Drug intelligence / Profile preview

Bupivacaine HCl + Morphine + Epinephrine + Methylprednisolone

Development stage
Unknown
Modality
Device-based Delivery → Drug Delivery Systems
Administration
Epidural, Intraarticular
01

Overview

This is a combination medication comprising four active ingredients: bupivacaine hydrochloride, morphine, epinephrine, and methylprednisolone. * **Bupivacaine HCl** is a local anesthetic that blocks nerve impulses to provide numbing effects. * **Morphine** is an opioid analgesic used for pain relief. * **Epinephrine** (adrenaline) is often included with local anesthetics to cause vasoconstriction, which prolongs the anesthetic effect and reduces systemic absorption. * **Methylprednisolone** is a corticosteroid with potent anti-inflammatory properties. This specific four-drug combination is used primarily in pain management settings, potentially for procedures requiring both immediate and prolonged pain relief along with reduction of inflammation. The combination might be administered via injection for regional anesthesia, possibly in epidural, intra-articular, or other localized applications. While individual components show compatibility in certain pairings (e.g., bupivacaine with morphine, bupivacaine with epinephrine, bupivacaine with methylprednisolone), the overall compatibility and stability of the specific four-drug mixture must be carefully evaluated. It appears to be utilized in clinical practice, particularly in pain management and potentially in palliative care.

02

Targets

MOR (Mu opioid receptor)GR (Glucocorticoid receptor)AR (Adrenergic receptors)NaV (Voltage-gated sodium channels)

Beyond the preview

Go deeper on Bupivacaine HCl + Morphine + Epinephrine + Methylprednisolone.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Bupivacaine HCl + Morphine + Epinephrine + Methylprednisolone.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call